Overview

Chemotherapy FOLFIRINOX in Advanced or Recurrent Cholangiocarcinoma

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the feasibility, efficacy and safety of FOLFIRINOX in advanced or recurrent cholangiocarcinoma
Phase:
Phase 2
Details
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Treatments:
Folfirinox